7 results
6-K
EX-10.2
BLRX
Bioline Rx Ltd
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
no release or to BioLine’s knowledge threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum
20-F/A
2015 FY
EX-4.40
BLRX
Bioline Rx Ltd
31 May 16
Annual report (foreign) (amended)
12:00am
, compounding, storage, filling, packaging, waste disposal, labeling, leafleting, testing, quality assurance, sample retention, stability testing, release
20-F/A
EX-4.38
9o2lcpd4gn6
23 Mar 15
Annual report (foreign) (amended)
12:00am
- Prev
- 1
- Next